[Development of additive systemic effects when taking β-blockers in patients with glaucoma
and concurrent chronic diseases]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Despite the broad prevalence and clinical significance of glaucoma, there is surprisingly
little in the way of evidence-based medicine to guide therapy. Although it is assumed that …

Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …

Beta-blockers in modern glaucoma therapy. Review | Kiseleva | Ophthalmology in Russia
Ophthalmology in Russia Oftalʹmologiâ eng | рус User ISSN 1816-5095 (Print) ISSN 2500-0845 …

Purpose: β-adrenergic receptor antagonists (β-blockers) used in the treatment of glaucoma
are an often-overlooked source of systemic adverse events. Ophthalmic timolol has been …

[Ocular hypotensive effect of systemic beta-blockers in patients with primary glaucoma and
arterial hypertension]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

OBJECTIVE: To review published clinical information on the systemic adverse effects of
ophthalmic β-blockers for the purpose of developing a pilot contraindication/warning system …

Purpose: Prescribing topical beta‐blockers for patients with glaucoma, who are also being
treated with systemic beta‐blockers, raises efficacy and safety concerns. This potentially …

The review is based on a survey of studies on adverse reactions related to topical
administration of beta-blockers for glaucoma. Locally applied beta-blocking agents are …

Beta-blockers are among the most important groups of drugs for glaucoma therapy. The
advantages of beta-blockers are a good efficacy in primary and secondary types of …